Zymeworks Inc. (NYSE:ZYME) Receives $21.00 Consensus Price Target from Brokerages
Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are presently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating on […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are presently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating on […]
